NFKB1 and Alzheimer disease: Therefore, suppression of neuroinflammation via inhibition of NF-κB signaling pathway can ameliorate neurodegeneration and memory impairment (Asanuma et al., 2004), which may be a beneficial strategy for AD treatment.